Autologous stem cell transplantation in Multiple Myeloma patients: an activity-based costing analysis, comparing a Total Impatient Model versus an Early Discharge Model

Activity-based costing (ABC) was developed and advocated as a means of overcoming the systematic distortions of traditional cost accounting. We calculated the cost of High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma patients using the ABC method, through two different care model: Total Inpatient Model (TIM) and Early-Discharge Outpatient Model (EDOM) and compared it with the approved Diagnosis Related Groups (DRG) Italian tariffs. TIM and EDOM models involved a total cost of € 28.615,15 and € 16.499,43, respectively.

Source: Clinical Lymphoma, Myeloma and Leukemia - June 6, 2017 Category: Hematology Authors: Massimo Martino, Giuseppe Console, Letteria Russo, Antonella Meliado ’, Roberta Fedele, Tiziana Moscato, Giuseppe Irrera, Giuseppe Messina, Antonella Pontari, Fortunato Morabito Source Type: research